These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27012168)

  • 41. Effect of implementing anti-HLA antibody detection by Luminex in the kidney transplant program in Chile.
    Elgueta S; Fuentes C; López M; Hernández J; Arenas A; Jiménez M; Gajardo JG; Rodríguez H; Labraña C
    Transplant Proc; 2011 Nov; 43(9):3324-6. PubMed ID: 22099789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies.
    Tambur AR; Audry B; Antoine C; Suberbielle C; Glotz D; Jacquelinet C
    Am J Transplant; 2017 Dec; 17(12):3149-3158. PubMed ID: 28597555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA Population Genetics in Solid Organ Transplantation.
    Kransdorf EP; Pando MJ; Gragert L; Kaplan B
    Transplantation; 2017 Sep; 101(9):1971-1976. PubMed ID: 28832450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allosensitization and outcomes in pediatric heart transplantation.
    Mahle WT; Tresler MA; Edens RE; Rusconi P; George JF; Naftel DC; Shaddy RE;
    J Heart Lung Transplant; 2011 Nov; 30(11):1221-7. PubMed ID: 21821435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS.
    Jackson KR; Covarrubias K; Holscher CM; Luo X; Chen J; Massie AB; Desai N; Brennan DC; Segev DL; Garonzik-Wang J
    Am J Transplant; 2019 Apr; 19(4):1129-1138. PubMed ID: 30372592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocation.
    Visentin J; Guidicelli G; Bachelet T; Jacquelinet C; Audry B; Nong T; Dubois V; Moreau JF; Lee JH; Couzi L; Merville P; Taupin JL
    Transplantation; 2014 Oct; 98(7):738-44. PubMed ID: 25289917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of Changes in New Calculated Panel Reactive Antibody Adopting HLA-Cw, DR51/52/53, and DQ Antigens in Koreans.
    In JW; Roh EY; Shin S; Park KU; Song EY
    Transplant Proc; 2016 Apr; 48(3):766-9. PubMed ID: 27234731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Practical value of identifying antibodies to cryptic HLA epitopes in cardiac transplantation.
    Oaks M; Michel K; Sulemanjee NZ; Thohan V; Downey FX
    J Heart Lung Transplant; 2014 Jul; 33(7):713-20. PubMed ID: 24661683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multicenter evaluation of a national organ sharing policy for highly sensitized patients listed for heart transplantation in Canada.
    Clarke B; Ducharme A; Giannetti N; Kim D; McDonald M; Pflugfelder P; Rajda M; Sénéchal M; Stadnick E; Toma M; Zieroth S; Isaac D
    J Heart Lung Transplant; 2017 May; 36(5):491-498. PubMed ID: 28162932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
    Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
    Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased Calculated Panel Reactive Antigen Is Associated With Increased Waitlist Time and Mortality in Lung Transplantation.
    Barac YD; Mulvihill MS; Jawitz O; Klapper J; Haney J; Daneshmand M; Nasir B; Chen D; Milano CA; Hartwig MG
    Ann Thorac Surg; 2020 Aug; 110(2):414-423. PubMed ID: 32251655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective trial of a predictive algorithm to transplant cadaver kidneys into highly sensitized patients.
    Thompson JS; Thacker L; Byrne J
    Transplantation; 2002 Apr; 73(8):1274-80. PubMed ID: 11981421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving equity in kidney transplant allocation policies through a novel genetic metric: The Matched Donor Potential.
    Tambur AR; Audry B; Glotz D; Jacquelinet C
    Am J Transplant; 2023 Jan; 23(1):45-54. PubMed ID: 36695620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tailoring antibody testing and how to use it in the calculated panel reactive antibody era: the Northwestern University experience.
    Tambur AR; Leventhal J; Kaufman DB; Friedewald J; Miller J; Abecassis MM
    Transplantation; 2008 Oct; 86(8):1052-9. PubMed ID: 18946342
    [TBL] [Abstract][Full Text] [Related]  

  • 56. cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator.
    Tinckam KJ; Liwski R; Pochinco D; Mousseau M; Grattan A; Nickerson P; Campbell P
    Am J Transplant; 2015 Dec; 15(12):3194-201. PubMed ID: 26080906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Calculated Panel Reactive Antibody Value on Waitlist Outcomes for Lung Transplant Candidates.
    Aversa M; Benvenuto L; Kim H; Shah L; Robbins H; Stanifer BP; D'Ovidio F; Vasilescu ER; Sonett J; Arcasoy SM
    Ann Transplant; 2019 Jun; 24():383-392. PubMed ID: 31249284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HLA-DQ barrier: effects on cPRA calculations.
    Tambur AR; Leventhal JR; Walsh RC; Zitzner JR; Friedewald JJ
    Transplantation; 2013 Dec; 96(12):1065-72. PubMed ID: 23995957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients.
    Hyun J; Park KD; Yoo Y; Lee B; Han BY; Song EY; Park MH
    Transplant Proc; 2012 Jan; 44(1):222-5. PubMed ID: 22310619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.